Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately.
International
●MDS: Clinical diagnostic criteria for Parkinson's disease (2015)
●MDS: Guidelines on diagnostic criteria for mild cognitive impairment in Parkinson's disease (2012)
Canada
●Parkinson Canada: Canadian guideline for Parkinson disease, 2nd edition (2019)
United States
●Choosing Wisely: Don't routinely use antipsychotics as first choice to treat behavioral and psychological symptoms of dementia (2013, revised 2015)
●American Academy of Neurology (AAN): Practice parameter – Initiation of treatment for Parkinson's disease: An evidence-based review (2002, reaffirmed 2005)
Europe
●EFNS/MDS-ES: Summary of the recommendations on therapeutic management of Parkinson's disease (2012)
United Kingdom
●NICE: Quality standard on Parkinson's disease (2018)
●NICE: Guideline on Parkinson's disease in adults (2017)
Japan
●[In Japanese] Japanese Neurological Society (JNS): Guidelines for treatment of Parkinson's disease (2011)